LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 26

Search options

  1. Book ; Online ; Thesis: Humorale Immunantwort nach monovalenter, adjuvantierter Impfung gegen die pandemische Influenza H1N1 (2009)

    Hauka, Sandra [Verfasser] / Adams, Ortwin [Gutachter] / MacKenzie, Colin [Gutachter]

    2023  

    Author's details Sandra Hauka ; Gutachter: Ortwin Adams, Colin MacKenzie
    Keywords Medizin, Gesundheit ; Medicine, Health
    Subject code sg610
    Language German
    Publisher Universitäts- und Landesbibliothek der Heinrich-Heine-Universität Düsseldorf
    Publishing place Düsseldorf
    Document type Book ; Online ; Thesis
    Database Digital theses on the web

    More links

    Kategorien

  2. Article ; Online: Real-world performance of the NeuMoDx™ HCV Quant Test for quantification of hepatitis C virus (HCV)-RNA.

    Lübke, Nadine / Walker, Andreas / Obermeier, Martin / Camdereli, Jennifer / Paluschinski, Martha / Walotka, Lara / Schupp, Anna-Kathrin / Tometten, Inga / Hauka, Sandra / Heger, Eva / Timm, Jörg

    Journal of virological methods

    2024  Volume 327, Page(s) 114937

    Abstract: Quantification of hepatitis C virus (HCV)-RNA in serum or plasma samples is an essential parameter in HCV diagnostics. Here, the NeuMoDx™Molecular System (Qiagen) was tested for the most common HCV genotypes and compared to the cobas c6800 system (Roche). ...

    Abstract Quantification of hepatitis C virus (HCV)-RNA in serum or plasma samples is an essential parameter in HCV diagnostics. Here, the NeuMoDx™Molecular System (Qiagen) was tested for the most common HCV genotypes and compared to the cobas c6800 system (Roche). HCV-RNA from 131 plasma/serum samples from chronically infected patients was determined in parallel on the NeuMoDx and c6800 systems. Linearity was analysed using the four most common HCV genotypes (1-4) in our cohort. The coefficient of variation (CV) within (intra-assay) and between (inter-assay) runs was calculated based on HCV-RNA concentration. Quantitative HCV-RNA results were highly correlated on both test systems (R
    Language English
    Publishing date 2024-04-11
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 8013-5
    ISSN 1879-0984 ; 0166-0934
    ISSN (online) 1879-0984
    ISSN 0166-0934
    DOI 10.1016/j.jviromet.2024.114937
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Adjusted COVID-19 booster schedules balance age-dependent differences in antibody titers benefitting risk populations.

    Müller, Lisa / Andrée, Marcel / Moskorz, Wiebke / Drexler, Ingo / Hauka, Sandra / Ptok, Johannes / Walotka, Lara / Grothmann, Ramona / Hillebrandt, Jonas / Ritchie, Anastasia / Peter, Laura / Walker, Andreas / Timm, Jörg / Adams, Ortwin / Schaal, Heiner

    Frontiers in aging

    2022  Volume 3, Page(s) 1027885

    Abstract: We provide follow-up data on the humoral immune response after COVID-19 vaccinations of two distinct cohorts aged below 60 and over 80 years to screen for age-related differences in the longevity and magnitude of the induction of the antibody responses ... ...

    Abstract We provide follow-up data on the humoral immune response after COVID-19 vaccinations of two distinct cohorts aged below 60 and over 80 years to screen for age-related differences in the longevity and magnitude of the induction of the antibody responses post booster-vaccinations. While anti-SARS-CoV-2 spike-specific IgG and neutralization capacity waned rapidly after the initial vaccination schedule, additional boosters highly benefitted the humoral immune responses especially in the elderly cohort, including the neutralization of Omikron variants. Thus, adjusted COVID-19 booster vaccination schedules are an appropriate tool to overcome limitations in the success of vaccinations.
    Language English
    Publishing date 2022-10-12
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 3076785-4
    ISSN 2673-6217 ; 2673-6217
    ISSN (online) 2673-6217
    ISSN 2673-6217
    DOI 10.3389/fragi.2022.1027885
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials.

    Lübke, Nadine / Senff, Tina / Scherger, Sara / Hauka, Sandra / Andrée, Marcel / Adams, Ortwin / Timm, Jörg / Walker, Andreas

    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

    2020  Volume 130, Page(s) 104579

    Abstract: Background: Fast and reliable detection of SARS-CoV-2 is crucial for efficient control of the COVID-19 pandemic. Due to the high demand for SARS-CoV-2 testing there is a worldwide shortage of RNA extraction reagents. Therefore, extraction-free RT-qPCR ... ...

    Abstract Background: Fast and reliable detection of SARS-CoV-2 is crucial for efficient control of the COVID-19 pandemic. Due to the high demand for SARS-CoV-2 testing there is a worldwide shortage of RNA extraction reagents. Therefore, extraction-free RT-qPCR protocols are urgently needed.
    Objectives: To establish a rapid RT-qPCR protocol for the detection of SARS-CoV-2 without the need of RNA extraction suitable for all respiratory materials.
    Material and methods: Different SARS-CoV-2 positive respiratory materials from our routine laboratory were used as crude material after heat inactivation in direct RT-qPCR with the PrimeDirect™ Probe RT-qPCR Mix (TaKaRa). SARS-CoV-2 was detected using novel primers targeted to the E-gene.
    Results: The protocol for the detection of SARS-CoV-2 in crude material used a prepared frozen-PCR mix with optimized primers and 5 μl of fresh, undiluted and pre-analytically heat inactivated respiratory material. For validation, 91 respiratory samples were analyzed in direct comparison to classical RNA-based RT-qPCR. Overall 81.3 % of the samples were detected in both assays with a strong correlation between both Ct values (r = 0.8492, p < 0.0001). The SARS-CoV-2 detection rate by direct RT-qPCR was 95.8 % for Ct values <35. All negative samples were characterized by low viral loads (Ct >35) and/or long storage times before sample processing.
    Conclusion: Direct RT-qPCR is a suitable alternative to classical RNA RT-qPCR, provided that only fresh samples (storage <1 week) are used. RNA extraction should be considered if samples have longer storage times or if PCR inhibition is observed. In summary, this protocol is fast, inexpensive and suitable for all respiratory materials.
    MeSH term(s) Betacoronavirus ; COVID-19 ; COVID-19 Testing ; Clinical Laboratory Techniques/methods ; Coronavirus Infections/diagnosis ; Coronavirus Infections/virology ; DNA Primers/genetics ; Humans ; Pandemics ; Pneumonia, Viral/diagnosis ; Pneumonia, Viral/virology ; RNA, Viral/analysis ; Real-Time Polymerase Chain Reaction/methods ; Respiratory System/virology ; SARS-CoV-2 ; Sensitivity and Specificity ; Specimen Handling/methods ; Time Factors
    Chemical Substances DNA Primers ; RNA, Viral
    Keywords covid19
    Language English
    Publishing date 2020-08-05
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2020.104579
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Adjusted booster schedules disperse age-dependent differences in antibody titers benefitting risk populations - Update to: Age-dependent Immune Response to the BioNTech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination

    Müller, Lisa / Andrée, Marcel / Moskorz, Wiebke / Drexler, Ingo / Hauka, Sandra / Ptok, Johannes / Walotka, Lara / Grothmann, Ramona / Hillebrandt, Jonas / Ritchie, Anastasia / Peter, Laura / Walker, Andreas / Timm, Jörg / Adams, Ortwin / Schaal, Heiner

    medRxiv

    Abstract: We provide follow-up data on the humoral immune response after COVID-19 vaccinations of a cohort aged below 60 and over 80 years. While anti-SARS-CoV-2 spike-specific IgG and neutralization capacity waned rapidly after initial vaccination, additional ... ...

    Abstract We provide follow-up data on the humoral immune response after COVID-19 vaccinations of a cohort aged below 60 and over 80 years. While anti-SARS-CoV-2 spike-specific IgG and neutralization capacity waned rapidly after initial vaccination, additional boosters highly benefitted humoral immune responses including neutralization of Omikron variants in the elderly cohort.
    Keywords covid19
    Language English
    Publishing date 2022-08-09
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2022.08.08.22278545
    Database COVID19

    Kategorien

  6. Article ; Online: Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials

    Lübke, Nadine / Senff, Tina / Scherger, Sara / Hauka, Sandra / Andrée, Marcel / Adams, Ortwin / Timm, Jörg / Walker, Andreas

    Journal of Clinical Virology

    2020  Volume 130, Page(s) 104579

    Keywords Virology ; Infectious Diseases ; covid19
    Language English
    Publisher Elsevier BV
    Publishing country us
    Document type Article ; Online
    ZDB-ID 1446080-4
    ISSN 1873-5967 ; 1386-6532
    ISSN (online) 1873-5967
    ISSN 1386-6532
    DOI 10.1016/j.jcv.2020.104579
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  7. Article: Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials

    Lübke, Nadine / Senff, Tina / Scherger, Sara / Hauka, Sandra / Andrée, Marcel / Adams, Ortwin / Timm, Jörg / Walker, Andreas

    J Clin Virol

    Abstract: BACKGROUND: Fast and reliable detection of SARS-CoV-2 is crucial for efficient control of the COVID-19 pandemic. Due to the high demand for SARS-CoV-2 testing there is a worldwide shortage of RNA extraction reagents. Therefore, extraction-free RT-qPCR ... ...

    Abstract BACKGROUND: Fast and reliable detection of SARS-CoV-2 is crucial for efficient control of the COVID-19 pandemic. Due to the high demand for SARS-CoV-2 testing there is a worldwide shortage of RNA extraction reagents. Therefore, extraction-free RT-qPCR protocols are urgently needed. OBJECTIVES: To establish a rapid RT-qPCR protocol for the detection of SARS-CoV-2 without the need of RNA extraction suitable for all respiratory materials. MATERIAL AND METHODS: Different SARS-CoV-2 positive respiratory materials from our routine laboratory were used as crude material after heat inactivation in direct RT-qPCR with the PrimeDirect™ Probe RT-qPCR Mix (TaKaRa). SARS-CoV-2 was detected using novel primers targeted to the E-gene. RESULTS: The protocol for the detection of SARS-CoV-2 in crude material used a prepared frozen-PCR mix with optimized primers and 5 µl of fresh, undiluted and pre-analytically heat inactivated respiratory material. For validation, 91 respiratory samples were analyzed in direct comparison to classical RNA-based RT-qPCR. Overall 81.3 % of the samples were detected in both assays with a strong correlation between both Ct values (r = 0.8492, p < 0.0001). The SARS-CoV-2 detection rate by direct RT-qPCR was 95.8 % for Ct values <35. All negative samples were characterized by low viral loads (Ct >35) and/or long storage times before sample processing. CONCLUSION: Direct RT-qPCR is a suitable alternative to classical RNA RT-qPCR, provided that only fresh samples (storage <1 week) are used. RNA extraction should be considered if samples have longer storage times or if PCR inhibition is observed. In summary, this protocol is fast, inexpensive and suitable for all respiratory materials.
    Keywords covid19
    Publisher WHO
    Document type Article
    Note WHO #Covidence: #694331
    Database COVID19

    Kategorien

  8. Article: Secondary sclerosing cholangitis as a complication of severe COVID-19: A case report and review of the literature.

    Klindt, Caroline / Jensen, Björn-Erik / Brandenburger, Timo / Feldt, Torsten / Killer, Alexander / Schimmöller, Lars / Antoch, Gerald / Senff, Tina / Hauka, Sandra / Timm, Jörg / Bahners, Bahne Hendrik / Seidl, Maximilian / Esposito, Irene / Luedde, Tom / Bode, Johannes G / Keitel, Verena

    Clinical case reports

    2021  Volume 9, Issue 5, Page(s) e04068

    Abstract: This case of secondary sclerosing cholangitis (SSC-CIP) emphasizes the need to provide follow-up care for patients that have recovered from COVID-19 in order to understand the complexity of SARS-CoV-2 associated sequela. ...

    Abstract This case of secondary sclerosing cholangitis (SSC-CIP) emphasizes the need to provide follow-up care for patients that have recovered from COVID-19 in order to understand the complexity of SARS-CoV-2 associated sequela.
    Language English
    Publishing date 2021-05-24
    Publishing country England
    Document type Case Reports
    ZDB-ID 2740234-4
    ISSN 2050-0904
    ISSN 2050-0904
    DOI 10.1002/ccr3.4068
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Age-dependent Immune Response to the Biontech/Pfizer BNT162b2 Coronavirus Disease 2019 Vaccination.

    Müller, Lisa / Andrée, Marcel / Moskorz, Wiebke / Drexler, Ingo / Walotka, Lara / Grothmann, Ramona / Ptok, Johannes / Hillebrandt, Jonas / Ritchie, Anastasia / Rabl, Denise / Ostermann, Philipp Niklas / Robitzsch, Rebekka / Hauka, Sandra / Walker, Andreas / Menne, Christopher / Grutza, Ralf / Timm, Jörg / Adams, Ortwin / Schaal, Heiner

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2021  Volume 73, Issue 11, Page(s) 2065–2072

    Abstract: Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to the development of various vaccines. Real-life data on immune responses elicited in the most vulnerable group of vaccinees older than age 80 years old are ... ...

    Abstract Background: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to the development of various vaccines. Real-life data on immune responses elicited in the most vulnerable group of vaccinees older than age 80 years old are still underrepresented despite the prioritization of the elderly in vaccination campaigns.
    Methods: We conducted a cohort study with 2 age groups, young vaccinees below the age of 60 years and elderly vaccinees over the age of 80 years, to compare their antibody responses to the first and second dose of the BNT162b2 coronavirus disease 2019 vaccination.
    Results: Although the majority of participants in both groups produced specific immunoglobulin G antibody titers against SARS-CoV-2 spike protein, titers were significantly lower in elderly participants. Although the increment of antibody levels after the second immunization was higher in elderly participants, the absolute mean titer of this group remained lower than the <60 years of age group. After the second vaccination, 31.3% of the elderly had no detectable neutralizing antibodies in contrast to the younger group, in which only 2.2% had no detectable neutralizing antibodies.
    Conclusions: Our data showed differences between the antibody responses raised after the first and second BNT162b2 vaccination, in particular lower frequencies of neutralizing antibodies in the elderly group. This suggests that this population needs to be closely monitored and may require earlier revaccination and/or an increased vaccine dose to ensure stronger long-lasting immunity and protection against infection.
    MeSH term(s) Age Factors ; Aged ; Aged, 80 and over ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; BNT162 Vaccine/immunology ; COVID-19/prevention & control ; Cohort Studies ; Female ; Humans ; Immunity ; Immunoglobulin G/blood ; Male ; Middle Aged ; Spike Glycoprotein, Coronavirus/immunology ; Vaccination
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral ; Immunoglobulin G ; Spike Glycoprotein, Coronavirus ; spike protein, SARS-CoV-2 ; BNT162 Vaccine (N38TVC63NU)
    Language English
    Publishing date 2021-04-26
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciab381
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Sensitivity of anti-SARS-CoV-2 serological assays in a high-prevalence setting.

    Müller, Lisa / Ostermann, Philipp Niklas / Walker, Andreas / Wienemann, Tobias / Mertens, Alexander / Adams, Ortwin / Andree, Marcel / Hauka, Sandra / Lübke, Nadine / Keitel, Verena / Drexler, Ingo / Di Cristanziano, Veronica / Hermsen, Derik Franz / Kaiser, Rolf / Boege, Friedrich / Klein, Florian / Schaal, Heiner / Timm, Jörg / Senff, Tina

    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

    2021  Volume 40, Issue 5, Page(s) 1063–1071

    Abstract: Evaluation and power of seroprevalence studies depend on the performed serological assays. The aim of this study was to assess four commercial serological tests from EUROIMMUN, DiaSorin, Abbott, and Roche as well as an in-house immunofluorescence and ... ...

    Abstract Evaluation and power of seroprevalence studies depend on the performed serological assays. The aim of this study was to assess four commercial serological tests from EUROIMMUN, DiaSorin, Abbott, and Roche as well as an in-house immunofluorescence and neutralization test for their capability to identify SARS-CoV-2 seropositive individuals in a high-prevalence setting. Therefore, 42 social and working contacts of a German super-spreader were tested. Consistent with a high-prevalence setting, 26 of 42 were SARS-CoV-2 seropositive by neutralization test (NT), and immunofluorescence test (IFT) confirmed 23 of these 26 positive test results (NT 61.9% and IFT 54.8% seroprevalence). Four commercial assays detected anti-SARS-CoV-2 antibodies in 33.3-40.5% individuals. Besides an overall discrepancy between the NT and the commercial assays regarding their sensitivity, this study revealed that commercial SARS-CoV-2 spike-based assays are better to predict the neutralization titer than nucleoprotein-based assays are.
    MeSH term(s) Adolescent ; Adult ; Aged ; Antibodies, Neutralizing/blood ; Antibodies, Viral/blood ; COVID-19/blood ; COVID-19/diagnosis ; COVID-19/epidemiology ; COVID-19 Serological Testing/methods ; COVID-19 Serological Testing/standards ; Contact Tracing ; Female ; Humans ; Immunoassay ; Male ; Middle Aged ; Neutralization Tests ; Prevalence ; SARS-CoV-2/immunology ; SARS-CoV-2/isolation & purification ; Sensitivity and Specificity ; Young Adult
    Chemical Substances Antibodies, Neutralizing ; Antibodies, Viral
    Language English
    Publishing date 2021-02-03
    Publishing country Germany
    Document type Comparative Study ; Journal Article
    ZDB-ID 603155-9
    ISSN 1435-4373 ; 0934-9723 ; 0722-2211
    ISSN (online) 1435-4373
    ISSN 0934-9723 ; 0722-2211
    DOI 10.1007/s10096-021-04169-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top